IQVIA Holdings Inc. (IQV) stock
IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3014% above fair value
$257.84+0.24 (+0.09%)
Close on Nov 18, 2026Market cap $42.49BP/E 31.3Yield –
Iqvia pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Iqvia's pe ratio was 34.1× on Nov 11, 2026, against 31.6× a year earlier. Over the last 5 years it ranged from 19.1× to 71.6×, with a median of 32.9×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 34.1× | +3.1 |
| 2025 | Dec 31, 2025 | 30.9× | +5.1 |
| 2024 | Dec 31, 2024 | 25.8× | −13.1 |
| 2023 | Dec 29, 2023 | 38.9× | +5.5 |
| 2022 | Dec 30, 2022 | 33.4× | −38.2 |
| 2021 | Dec 31, 2021 | 71.6× | −125.3 |
| 2020 | Dec 31, 2020 | 196.9× | +70.2 |
| 2019 | Dec 31, 2019 | 126.7× | +106.2 |
| 2018 | Dec 31, 2018 | 20.4× | −244.2 |
| 2017 | Dec 29, 2017 | 264.6× | +241.3 |
| 2016 | Dec 30, 2016 | 23.3× | −0.1 |
| 2015 | Dec 31, 2015 | 23.4× | +0.6 |
| 2014 | Dec 31, 2014 | 22.8× | −7.9 |
| 2013 | Dec 31, 2013 | 30.7× | – |
See a number that looks wrong?